Dr. Sachin A. Silva currently serves under the office of the UN Special Envoy for Tuberculosis. He has previously served as a consultant to the World Health Organization, the Organization for Economic Co-operation and Development, the Bill and Melinda Gates Foundation, the Foundation for Innovative New Diagnostics, several multinational pharmaceutical companies and national governments in Africa, Asia and Latin America. Sachin has also held a longstanding career in business where as a senior executive he led large-scale transformations for financial services, healthcare and life sciences organizations. As a management consultant, he has also advised organizations on growth, commercialization, operations and technology.

Sachin’s doctoral work at Harvard focused on the issue of undervaluation in vaccine investment decision-making. The work has been empirically and translationally motivated and linked with evaluations of candidate vaccines for major infectious diseases such as Tuberculosis. As his interests are in understanding the broader economic and societal consequences of high-burden diseases, his prior work has also included the estimation of the economic and social burden of diseases, the evaluation of various disease control interventions and the development of methods to augment financing toward disease control programs.

Sachin received his doctorate from Harvard University, his MSc and DIC from Imperial College London (UK) and his previous doctoral training from Yale University.